Cover Image

IVIG and under Burn Unit Care Yield Favorable Outcomes in Pediatric Patients with Toxic Epidermal Necrolysis: A Case Report and Literature Review

Body reactions to drugs can manifest as Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). TEN is the most severe form of cutaneous reactions with an incidence rate of 1-2 per million cases per year. Despite TEN being a critical and life-threatening condition, there is little to no...

Full description

Saved in:

Bibliographic Details
Main Authors:	Tareq Z. Alzughayyar (Author), Wasim Noureddin Ibrahim Hamad (Author), Eman A. S. Abuqweider (Author), Bilal Nabeel Mohammad Alqam (Author), Sadi A. Abukhalaf (Author), Rami A. Misk (Author), Fawzy M. Abunejma (Author), Jihad Samer Zalloum (Author), Mohanad Saleh (Author), Ali A. Abumunshar (Author), Yousef I. M. Zatari (Author)
Format:	Book
Published:	Hindawi Limited, 2020-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A Case Report and Literature Review of Pseudo-TORCH Syndrome Type 2 (PTORCH2)
by: Rami A. Misk, et al.
Published: (2022)

Intrauterine Limb Ischemia in Patient Heterozygous for the 677C>T) RS1801133 (Polymorphism of Methylenetetrahydrofolate Reductase MTHR Gene
by: Ahmad Al Hammouri, et al.
Published: (2022)

H-type anorectal malformation associated with H-type tracheoesophageal fistula
by: Sadi A. Abukhalaf, et al.
Published: (2019)

Treatment of scleromyxedema with IVIg
by: Moser David W, et al.
Published: (2012)

Eczematous reaction to IVIG for the treatment of dermatomyositis
by: J. Berk-Krauss, et al.
Published: (2018)

IVIG Effects on Erythrocyte Sedimentation Rate in Children
by: Farhad Salehzadeh, et al.
Published: (2014)

MIS-C Treatment: Is IVIG Always Necessary?
by: Francesco Licciardi, et al.
Published: (2021)

The effects of hair regrowth with intravenous immunoglobulin (IVIG) therapy. Two case reports
by: Joseph A. Cahill, et al.
Published: (2017)

Intravenous Immunoglobulin G (IVIG) Need Assessment Survey Toward Local Manufacturing of IVIG Using a Mini-Pool Plasma Fractionation Technique
by: Bisrat Bekele, et al.
Published: (2023)

Corrigendum: MIS-C Treatment: Is IVIG Always Necessary?
by: Francesco Licciardi, et al.
Published: (2022)

Economic impact of infections among patients with primary immunodeficiency disease receiving IVIG therapy
by: Menzin J, et al.
Published: (2014)

IVIG induced Hemolytic anemia - A report of two cases
by: Putun Patel, et al.
Published: (2017)

IVIG-Associated Maternal Pancytopenia during Treatment for Neonatal Alloimmune Thrombocytopenia
by: Alyssa Herrmann, et al.
Published: (2017)

Absence of Anti-Babesia microti antibody in commercial intravenous immunoglobulin (IVIG).
by: Julia Kostka, et al.
Published: (2024)

Retreatment with intravenous immunoglobulin (IVIG) of refractory Guillain Barre syndrome in children
by: Rivas Larrauri Francisco, et al.
Published: (2014)

IVIG Treatment Response and Age are Important for the Prognosis of Pediatric Immune Thrombocytopenia
by: Min Gi Sakong, et al.
Published: (2022)

Epidermal necrolysis (Stevens-Johnson syndrome and toxic epidermal necrolysis): Historical considerations
by: Jean-Claude Roujeau
Published: (2013)

Skin Detachment and Regrowth in Toxic Epidermal Necrolysis
by: Laurence Feldmeyer, et al.
Published: (2010)

The expression of autophagy markers in IVIG-resistant Kawasaki disease and the establishment of prediction model
by: Yang Zhou, et al.
Published: (2023)

Perforated Sigmoid Diverticulitis in the Presence of Toxic Epidermal Necrolysis
by: P. Heye, et al.
Published: (2014)

Cyclosporine in Stevens-Johnson syndrome and toxic epidermal necrolysis: Current scenario
by: Keshavmurthy A Adya
Published: (2018)

Cost-minimisation analysis of plasma exchange versus IVIg in the treatment of autoimmune neurological conditions
by: Tara Klemencic Kozul, et al.
Published: (2022)

Cost-minimization analysis of the direct costs of TPE and IVIg in the treatment of Guillain-Barré syndrome
by: Chainani Ashok, et al.
Published: (2011)

Comparison of second-line therapy in IVIg-refractory Kawasaki disease: a systematic review
by: Courtney B. Crayne, et al.
Published: (2019)

Toxic epidermal necrolysis associated with deflazacort therapy with nephrotic syndrome
by: Eun Chae Lee, et al.
Published: (2014)

Fulvestrant-induced toxic epidermal necrolysis
by: Macarena Morales-Conde, et al.
Published: (2019)

Toxic epidermal necrolysis management with suprathel™
by: Miriam Miguel-Ferrero, et al.
Published: (2023)

Liver Failure and Conjugated Hyperbilirubinemia in a Preterm Neonate: Role of Early IVIG and Exchange Transfusion
by: Jayasree Nair, et al.
Published: (2018)

Positive hepatitis B serology following IVIg treatment in a patient with mucous membrane pemphigoid
by: Ryan Colakovic, BS, et al.
Published: (2021)

Efficacy of intravenous immunoglobulins (IVIG) in COVID-19 patients: a systematic review and meta-analysis
by: Behzad Fatemi, et al.
Published: (2023)

Association between P2RY12 Gene Polymorphisms and IVIG Resistance in Kawasaki Patients
by: Zhouping Wang, et al.
Published: (2020)

Evaluating the performance of egami, kobayashi and sano scores in predicting IVIG resistance in infant kawasaki disease
by: Young Tae Lim, et al.
Published: (2024)

Drug Use Evaluation of Human Intravenous Immunoglobulin (IVIG) in a Teaching Hospital in East of Iran
by: Mandana Moradi, et al.
Published: (2018)

Successful Treatment of Severe Pemphigus Vulgaris with Reduced Side Effects Using a Novel IVIg Preparation
by: Nadine Wiedenmayer, et al.
Published: (2024)

The Comparison of Two Types of Treatment (High Dose and Low Dose IVIG) in Children with GBS in Mofid Hospital
by: Parvaneh Karim-Zadeh, et al.
Published: (2003)

230 Establishing a risk stratification scoring system for ivig resistance in kawasaki disease in Hong Kong
by: Lai Ling Hui, et al.
Published: (2021)

A Case of Contact Toxic Epidermal Necrolysis
by: Weiwei Jiang, et al.
Published: (2024)

Toxic epidermal necrolysis induced by COVID-19
by: Duaa Alahmadi, et al.
Published: (2024)

Epidermic toxic necrolysis induced by co-trimoxazole
by: Rolando Rodríguez Hernández, et al.
Published: (2016)

Functional benefits of corticosteroid and IVIG combination therapy in a coronary artery endothelial cell model of Kawasaki disease
by: Takashi Inoue, et al.
Published: (2020)